openPR Logo
Press release

Artificial Retina Market - Nano-Retina, Second Sights, and Optobionics

08-24-2018 12:37 PM CET | Health & Medicine

Press release from: CMI - Medical Devices

Artificial Retina Market

Artificial Retina Market

Artificial Retina Market is a major breakthrough in medical devices industry, wherein many universities and leading medical devices companies are conducting research to offer vision to over 285 million visually impaired population worldwide. These devices are mainly nanorod carbon nanotube biomimetic films along with accessory devices such as transmitter and video processing unit (VPU). As such progressive development towards artificial retina is expected to create high ROI for engaged in early development of the product. A lot of players in the artificial retina market are making major investments in R&D activities related to the same. These devices are expected to cater to various visual impaired conditions ranging from age-related macular degeneration (AMD) to retinispigmentosa (RP).

Request Sample Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/13

Artificial Retina Market Dynamics

Product innovation is a key artificial retina market trend. The ophthalmic industry has become more competitive over the last few years. Established ophthalmic product categories have become more mature, in turn offering low level of market opportunity for players. Most companies are emphasizing on price level strategy in order to enhance their business presence worldwide. However, the pricing trend could potentially benefit the company on a shorter scale during the forecast period. Most major players stand to gain from investing in R&D activities to capitalize on long-term lucrative opportunities due to patent products and innovative technologies. In recent times, the artificial retina market has also witnessed the emergence of various startups especially in the high growth markets for U.S. and Israel. Artificial retina would create value-oriented customers in near future for these manufacturers.

Download PDF Copy of this Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/13

Key Vendors of Artificial Retina Market: Nano-Retina, Second Sights, and Optobionics.
Artificial Retina Market Regional Analysis

North America and Europe are expected to dominate the overall artificial retina market throughout the forecast period (2016–2024). This is primarily attributed to robust healthcare infrastructure and high spending on healthcare R&D in these regions. The healthcare industry in North America is undergoing major transformation following the implementation of various healthcare reforms. Moreover, the region is home to over 10 million visually impaired population seeking effective treatment. Every year, 50 thousand people go blind in North America. Advancements in development of artificial retina is projected to create lucrative growth opportunities for market players in the region. Most of the countries in Europe and North America have healthcare spending of over 10% of overall GDP.

Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/13

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Artificial Retina Market - Nano-Retina, Second Sights, and Optobionics here

News-ID: 1199815 • Views: 222

More Releases from CMI - Medical Devices

Varicose Vein Treatment Devices Market Headed for Growth and Global Expansion by …
Varicose Veins form in the leg due to flow of blood in the opposite direction, which creates extreme pressure in the already blocked veins. Varicose veins can lead to ulceration, swelling, and venous eczema. The condition can significantly hamper quality of life. Over 40% of total U.S. population is affected by varicose veins and over 30 million U.S. citizens suffer from venous insufficiency and the risk of developing varicose veins
Hernia Repair Devices and Consumables Market Explore Future Growth 2017-2025 by …
A Hernia is bulging of an organ or tissue through an abnormal opening. It occurs when an organ or any other body part protrudes through the wall of tissue or muscle. The organs that bulges out from the body is usually abdominal fatty tissue or intestinal portions, which are present in the thin membrane that lines the inside cavity. Symptoms of a hernia can be observed during certain activities such
Implantable Cardioverter-defibrillators Market Future and Technological Advancem …
An ICD or implantable cardioverter-defibrillator is a battery-operated device that is placed under the skin of the patient to monitor the user’s heart rate. ICDs are connected to the heart by thin wires. In cases where an abnormal heart beat is detected, implantable cardioverter-defibrillator deliver an electric shock to reinstate a normal heart rhythm if the patient’s heart is beating too fast. Implantable cardioverter-defibrillators have been useful in thwarting sudden
Biopsy Devices Market to Register Unwavering Growth to 2026 by Global Top Player …
A biopsy is a sample of tissue taken from the body for in-depth analysis of the sample to reach an effective diagnosis of a condition, wherein conventional diagnostic methods such as x-rays and body scans do not provide any conclusive evidence. Biopsies are usually carried out to detect cancer, though their application is not restricted to it. This procedure is mostly performed by interventional radiologists, cardiologist and surgeons. Biopsy might

All 5 Releases


More Releases for Artificial

Artificial Paintings Releases NFT
Artificial Paintings - a tech company that trained AI to create works of digital art - has transformed its AI-driven digital paintings into NFTs. The company has already presented more than a hundred of NFTs and plans to keep releasing more. An NFT (non-fungible token) is a unique piece of digital artwork stored on a digital ledger. Non-fungible means that the digital asset is not interchangeable. In 2021, the NFT
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Artificial intelligence for industrial microbiology
Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. It is able to quantify and specifically identify single cells directly and without time-consuming enrichment steps. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology. In contrast to conventional rapid test methods, the
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells.  For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard and
Global Artificial Intelligence Market
According to a new report, Global Artificial Intelligence Market (2016-2022), published by KBV Research, the global artificial intelligence market is estimated to reach USD 16,274.0 Million by 2022, at a CAGR of 44.5% from 2016 to 2022. The North America market dominated the Global Artificial Intelligence Market in 2015, and would continue to be a dominant market till 2022; thereby growing at a CAGR of 42.7% during the forecast period.